As displayed by our experiments, lncRNA PURPL targeted and hampered miR-137, elevated the profile of ZBTB7A, activated the PI3K/AKT/NF-κB pathway, and stepped up GC occurrence and development. The gene discussed is AKT1; the disease is gastric cancer.